Why Your Testosterone Result Depends on the Assay: LC-MS/MS, Direct Free-T, and Standardization

Two blood draws can hand the same man two different testosterone numbers, and the assay is often the reason. The 2018 Endocrine Society clinical practice guideline recommends a fasting, morning sample measured with an accurate and reliable assay, ideally accuracy-standardized liquid chromatography-tandem mass spectrometry (LC-MS/MS), and confirmed by repeating the measurement on a second morning. Direct free-testosterone immunoassays, the analog kits many labs run, are considered unreliable, so equilibrium dialysis or a validated calculation is preferred when the total value sits near the lower limit. Before anyone concludes a number is low, the method that produced it deserves a look.

The number is a measurement, not a fact about your body

A testosterone result is the output of a chemical method, and different methods disagree. Historically the disagreement was severe. The literature reviewed in a 2018 harmonization analysis notes that older immunoassays produced results up to five-fold higher than mass spectrometry in women, and one editorial went so far as to say that for female-range testosterone, guessing would be more accurate. That is not a rhetorical flourish about a rare edge case; it is a statement about the physics of the assay at low concentrations.

Immunoassays work by binding testosterone with an antibody. At the higher concentrations typical of adult men they can perform acceptably, but antibodies cross-react with structurally similar steroids, and that interference dominates the signal when the true concentration is low. LC-MS/MS instead separates testosterone physically and identifies it by mass, which gives it the specificity and sensitivity to measure the low ranges seen in women, children, and hypogonadal men. This is why LC-MS/MS is described as the reference approach in these populations, not a marketing upgrade.

Standardization is what makes two labs comparable

Being a mass spectrometer is not enough; the instrument still has to be calibrated against a common yardstick. That yardstick is the CDC Hormone Standardization (HoSt) Program, which ties assays back to reference measurement procedures and NIST reference material. The 2018 harmonization study makes the payoff concrete: four independently developed LC-MS/MS assays, once calibrated to NIST Standard Reference Material 971, achieved a mean bias under 5 percent across concentrations from roughly 3.7 to 1098 ng/dL. The CDC program targets a mean bias within about plus or minus 6.4 percent so that results are comparable across methods, laboratories, and time.

The 2018 Endocrine Society guideline folds this into practice by advising clinicians to measure total testosterone with a CDC-certified assay or one verified through an accuracy-based external quality program. The practical translation for a reader: a result from a standardized platform can be compared against the reference intervals in the guideline, while a result from an uncertified assay is measuring in its own private units. The catch is that certification participation is cost prohibitive for many laboratories, so standardization is not universal, and the ordering clinician cannot always assume it.

Free testosterone is where the cheap shortcut fails

Most circulating testosterone is bound to sex hormone-binding globulin (SHBG) and albumin, and only a small fraction is free. When total testosterone is borderline or when a condition shifts SHBG, such as obesity, aging, thyroid disease, or diabetes, the free fraction can tell a different story than the total. The Endocrine Society guideline addresses exactly this situation: in men whose total testosterone is near the lower limit, or who have an SHBG-altering condition, it recommends obtaining free testosterone by equilibrium dialysis or estimating it with an accurate formula from total testosterone, SHBG, and albumin.

What the guideline steers away from is the direct free-testosterone immunoassay, sometimes labeled an analog method, which is widely available and inexpensive. It is considered unreliable because it does not physically separate the free fraction and is sensitive to the same binding-protein effects it is meant to see past. Equilibrium dialysis physically separates free from bound hormone and is the reference method; a validated calculation is the accessible alternative. If a lab report shows a direct free-T value that conflicts with the clinical picture, the method itself is a plausible culprit.

Timing can move a normal man into the low column

Testosterone is not a fixed quantity you carry around. As reviewed by Caliskan Guzelce and Bhasin in 2022, secretion is pulsatile and follows a circadian rhythm, peaking in the morning and drifting lower through the day, with additional variation across seasons and with food intake. A sample drawn in the afternoon, or after a meal, can read lower than the same man would show fasting at 8 a.m. This is precisely why the guideline specifies fasting morning measurement and why a single low value is not a diagnosis. Because levels fluctuate, the guideline asks for confirmation on a second morning before labeling testosterone deficiency, and it restricts the diagnosis to men who also have consistent symptoms and signs. A number without symptoms, or a number without a repeat, is an incomplete picture.

What this means for reading a report

None of this tells any individual what their result means; this article is educational and is not medical advice. The useful habit is to interrogate the conditions of the measurement rather than the digit alone: Was it drawn fasting in the morning? Was it repeated? Was total testosterone run on a standardized LC-MS/MS platform? If free testosterone mattered, was it obtained by dialysis or a calculation rather than a direct immunoassay? A borderline result generated on an unstandardized assay, in the afternoon, without a repeat, carries far less weight than the same digit produced under the conditions the guideline describes. Whether that number warrants any further evaluation is an individual decision to work through with a clinician who can see the whole context.